Cargando…
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans
BACKGROUND: Emerging research seeking novel analgesic drugs focuses on agents targeting group-II metabotropic glutamate receptors (mGlu2 and mGlu3 receptors). N-Acetylcysteine (NAC) enhances the endogenous activation of mGlu2/3 receptors by activating the glial glutamate:cystine membrane exchanger....
Autores principales: | Truini, Andrea, Piroso, Serena, Pasquale, Erica, Notartomaso, Serena, Di Stefano, Giulia, Lattanzi, Roberta, Battaglia, Giuseppe, Nicoletti, Ferdinando, Cruccu, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379592/ https://www.ncbi.nlm.nih.gov/pubmed/25889381 http://dx.doi.org/10.1186/s12990-015-0009-2 |
Ejemplares similares
-
N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
por: Bernabucci, Matteo, et al.
Publicado: (2012) -
Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortex
por: Mascio, Giada, et al.
Publicado: (2021) -
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
por: Notartomaso, Serena, et al.
Publicado: (2013) -
Light-Induced Activation of a Specific Type-5 Metabotropic Glutamate Receptor Antagonist in the Ventrobasal Thalamus Causes Analgesia in a Mouse Model of Breakthrough Cancer Pain
por: Notartomaso, Serena, et al.
Publicado: (2022) -
N-Acetylcysteine causes analgesia in a mouse model of painful
diabetic neuropathy
por: Notartomaso, Serena, et al.
Publicado: (2020)